Matthew J. Maurer, ScD

Associate Professor of Biostatistics & Medicine at Mayo Clinic

[Amylou Dueck, PhD @BiostatGirl]

2nd annual heme statistician meetup at #ASH25 (group photo coming soon)! Thanks to @MaurerStats for organizing! I continue to be impressed with @ASH_hematology’s support of biostatisticians! Be sure to check out the Stat Spotlight Session on Monday at 10:30am!!

[Matthew J. Maurer, ScD @MaurerStats]

We will be presenting details on our FLP-R prognostic model and trial enrichment tool for R/R follicular #lymphoma at the Monday poster session of #ASH25. The model calculator is available at https://t.co/v1tLPoacU9

#lymsm

#lymsm

[John P. Leonard, MD @JohnPLeonardMD]

Now for #LeonardList 2 in countdown of #ASH2025 #ASH25 top #lymphoma abstracts - Seheult et al abst 117: Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma
classification and subtyping https://t.co/bdfZGjWFQK

[John P. Leonard, MD @JohnPLeonardMD]

#LeonardList 2 in countdown of #ASH2025 #ASH25 top #lymphoma abstracts - Seheult et al abst 117: Lymphovision...A neural network being trained to identify lymphoma/non-lymphoma, lymphoma type/subtype & potentially even mutation profiling and prognosis https://t.co/bdfZGjWFQK

[Vít Procházka 🇨🇿🇪🇺🇺🇦 @vit_prochazka]

Best clinical FL POD24 predicttion tool on-line! https://t.co/h35TMX0Z69 🎄Proud to be 2nd author.
👏Heroic and practice changing work led by @MaurerStats and James Cerhan. Strong data (a lot pts from 🇨🇿), kudos to @MarekTrnenyDr

🧮 easily ➡️ https://t.co/VTdlv6CHQM

[Jonathan Friedberg @DrJFriedberg]

Our FLIPI24: Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma. Thanks to @MaurerStats and entire LEO team for this collaboration. @JCO_ASCO
https://t.co/tHIYhRQLBr

[Matthew J. Maurer, ScD @MaurerStats]

Our manuscript on the FLIPI24 prognostic model and clinical trial enrichment tool for newly diagnosed #follicular lymphoma is now online @JCO_ASCO :

https://t.co/pLWiONtxOX

Link to online calculator: https://t.co/iHAuN8gacB

#lymsm

[NEJM Evidence @NEJMEvidence]

𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝!

Original Article: “An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma” by A.M. Rodday (@AngieRodday) et al. https://t.co/zuxJTV8jxG

@DrAEvens @TuftsMedicalCtr @TuftsMCResearch @RutgersCancer @RWJBarnabas @icmlugano #18ICML

[Eddie Cliff @Eddie_Cliff]

Dr @GregNowakowski gives nice overview of the >30-year-old IPI, international prognostic index, in DLBCL, + various more recent attempts to prognosticate in DLBCL

@MaurerStats's analysis of outcomes by days to treatment initiation particularly interesting

#EHA2025 #lymsm

[Mengyang Di, MD PhD @DiMengyang]

Our review is just out in @BloodJournal

Endpoints and outcomes in follicular lymphoma https://t.co/R6rvSESQBK

Great collaboration with @ChrisRFlowersMD @MaurerStats

@fredhutch @uwmnewsroom